Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Rtnew SP Artesunate Sulphadoxine & Pyrimethamine Combikit
Rtnew SP provides a comprehensive treatment option for malaria, targeting multiple stages of the parasite's lifecycle. The inclusion of Artesunate, a fast-acting antimalarial, along with Sulphadoxine and Pyrimethamine, ensures broad-spectrum efficacy and helps prevent the spread of resistant strains.
Uses of Rtnew SP Artesunate Sulphadoxine & Pyrimethamine Combikit
Malaria Treatment: Specifically effective against Plasmodium falciparum malaria, including strains resistant to other antimalarials.
Malaria Control: Can be used in regions with high prevalence of malaria to control outbreaks and prevent transmission.
Combination Therapy: Often prescribed as part of combination therapy to ensure comprehensive parasite clearance and reduce recurrence.
Benefits of Rtnew SP Artesunate Sulphadoxine & Pyrimethamine Combikit
Rapid Parasite Clearance: Artesunate acts quickly to reduce parasite burden, alleviating symptoms and preventing complications.
Resistance Management: The combination of Sulphadoxine and Pyrimethamine helps prevent the development of resistance, a significant issue in malaria treatment.
Convenient Dosing: Combikit format simplifies administration, improving adherence to treatment regimens.
Comprehensive Coverage: Targets both asexual and sexual stages of the parasite, ensuring thorough eradication.
Mechanism of Action of Rtnew SP Artesunate Sulphadoxine & Pyrimethamine Combikit
Artesunate: A derivative of artemisinin, it generates free radicals that damage the parasite's cell membranes, leading to rapid killing of the parasite.
Sulphadoxine & Pyrimethamine: These two drugs work synergistically to inhibit folic acid synthesis in the parasite, which is essential for its replication and survival. By blocking different steps in the folic acid pathway, they ensure effective parasite elimination.